| Yesterday | ||||
Axon and RapidSOS… Axon and RapidSOS announced a partnership to provide emergency first responders and 911 telecommunicators access to critical emergency incident information from Axon devices being used by law enforcement officers. Through this partnership, Emergency Communication Centers across the U.S. will be eligible to access the location of officers, real-time alerts resulting from developing situations, and streaming video through Axon Respond devices such as Axon body-worn cameras, Axon Fleet in-car cameras, and Axon Air connected drones. Additionally, emergency intelligence data from more than 350 million connected devices recognized as RapidSOS Ready will be available to dispatchers and first responders via Axon Respond. | ||||
| Tuesday | ||||
| Over a month ago | ||||
Axon and Skydio announced… Axon and Skydio announced a strategic partnership to offer Skydio's autonomous drones to law enforcement and emergency responders via Axon's unmanned aircraft program, Axon Air. As a Skydio Elite Partner, Axon will be the exclusive reseller and digital evidence management partner of Skydio's products to public safety globally. In addition, the two companies are working on a joint product roadmap that, in the coming months, will lead to the seamless integration between Skydio drones and Axon Air, Axon Evidence, and Axon Respond | ||||
Axon announced that the… Axon announced that the Ministry of the Solicitor General of Ontario is deploying Axon's digital evidence management solution, Axon Evidence, to the Ontario Provincial Police and multiple municipal police services across Ontario. This modernization initiative will connect all Ontario justice sector partners and stakeholders, including the police, courts, crown attorneys, defence counsel and corrections. Axon Evidence is a Canadian cloud-based digital evidence platform that allows agencies and investigators to store, manage, transfer and share digital evidence across all public safety agencies. Axon was selected through the province's open and competitive procurement process for a provincial digital evidence management solution. As a part of this announcement, the Ministry will also be supporting public submission of digital evidence via Axon Citizen. | ||||
Baird analyst William… Baird analyst William Power raised the firm's price target on Axon to $200 from $135 and keeps an Outperform rating on the shares. The analyst noted its raised guidance and recent results which were driven by Taser which netted the company's largest win in its history. He expects its revised guidance remains conservative but sees it supported by strong growth trends and its strong competitive position. | ||||
Consensus for FY21… Consensus for FY21 revenue is $742.24M. Raises 2021 adjusted EBITDA view to $125M-$140M from $140M-$130M. Sees 2021 CapEx $65M-$70M. | |
Reports Q4 revenue $226M,… Reports Q4 revenue $226M, consensus $180.96M. The company stated, "In 2020, we solidified the foundation for our next decade of growth. First and foremost, we served our customers, team members and communities during a global pandemic. At the same time, we secured our first Dispatch customer, established a solid foothold in the Federal market, launched our Respond platform and grew our international revenue by more than 70%. We are proud to have delivered a record $681M in revenue, representing 28% growth, $1.2B in contract bookings, and $221M in annual recurring revenue. We wrapped up the year with an exceptional Q4, highlighted by revenue growth of 32%, strong profitability and robust global demand for our TASER devices. The results showcase the leverage in our business model". | |
Catch up on today's… Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alnylam (ALNY) downgraded to Neutral from Buy at Citi with analyst Joel Beatty believing share upside will be limited by a "growing appreciation by the Street of competitors' threats" to the company's ATTR business by both acoramidis and gene editing. 2. Iridium (IRDM) double downgraded to Underweight from Overweight at Barclays with analyst Mathieu Robilliard saying the stock price "has run above fundamentals." 3. Amicus (FOLD) downgraded to Neutral from Overweight at JPMorgan and Cantor Fitzgerald, and downgraded to Market Perform from Outperform at SVB Leerink. 4. Williams-Sonoma (WSM) downgraded to Perform from Outperform at Oppenheimer with analyst Brian Nagel saying while he remains upbeat towards longer-term fundamental prospects for Williams-Sonoma, the analyst is increasingly concerned in the near-term that now more elevated Street forecasts could prove too optimistic as broader trends in spending likely normalize and comparisons turn more challenging. 5. Axon (AXON) downgraded to Neutral from Overweight at JPMorgan with analyst Mark Strouse saying with the shares up 66% year-to-date, significantly outperforming peers, Axon "could trade sideways for a period." click here. | |
JPMorgan analyst Mark… JPMorgan analyst Mark Strouse downgraded Axon Enterprise to Neutral from Overweight with a price target of $179, up from $129. With the shares up 66% year-to-date, significantly outperforming peers, Axon "could trade sideways for a period," Strouse tells investors in a research note. The analyst's long-term thesis is unchanged as he expects "solid momentum" to continue within the weapons and Axon cloud businesses, and he believes traction with U.S. federal and/or international agencies could present upside to current forecasts. Strouse believes long-term investors should hold existing positions, "potentially buying on dips." | |